1,3-propanediol has been researched along with Cerebral Palsy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
PHELPS, WM | 1 |
PHELPS, WM; SPEARS, CE | 1 |
2 other study(ies) available for 1,3-propanediol and Cerebral Palsy
Article | Year |
---|---|
Preliminary institutional evaluation of a new drug in cerebral palsy: N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (soma).
Topics: Carisoprodol; Cerebral Palsy; Health Facilities; Muscle Relaxants, Central; Propylene Glycol; Propylene Glycols | 1959 |
Preliminary trial of a new muscle relaxant; nisopropyl-2-methyl-2-propyl-1,3 propanediol dicarbamate (soma) in outpatient children with cerebral palsy.
Topics: Carisoprodol; Cerebral Palsy; Muscle Relaxants, Central; Outpatients; Propylene Glycol; Propylene Glycols | 1959 |